Product
A dashboard-based biomarker intelligence platform for performance, body composition, recovery, and longevity goals.
Platform Methodology
A concise technical summary of Exia Bio’s AI-native platform.
handshakeFor partners, evaluators & press
A formal methodology summary for institutional review, partnership evaluation, and press research.
This is not a customer product page. First-time visitors should start with How It Works. For the engine behind the product, see Technology.
For deeper detail, review the Technology and Sentinel Architecture pages.
Report reality before Sentinel
Existing blood reports arrive with different formats, marker sets, lab conventions, and missing advanced signals. Sentinel starts by structuring this source context before any educational output is produced.
Illustrative report-context visual — not a Sentinel dashboard, customer interface, or final delivered report.
Executive Summary
What Exia Bio is building
AI Role
AI supports report structuring, data normalization, missing-marker detection, and dashboard-ready preparation.
Logic Layer
Biomarkers are calibrated by pathway and interpreted as interacting biological systems.
Boundary
Exia Bio provides non-diagnostic educational analytics and does not provide diagnosis, treatment, prescription, or emergency review.
Technical Thesis
Biomarkers are interacting signals, not isolated lab values.
Exia Bio treats blood reports as structured data inputs. The platform maps biomarkers into interacting systems, selected user pathways, missing-marker gaps, and longitudinal dashboard outputs.
System workflow
01 · Upload
Existing report or new biomarker data enters the workflow.
02 · Structure
Report values, units, dates, and reference intervals are extracted and cleaned.
03 · Normalize
Messy report data becomes structured biomarker records.
04 · Calibrate
Pathway and cross-marker logic generate friction signals and confidence flags.
05 · Review
Launch-stage quality checks reduce obvious completeness and report-reading issues.
06 · Deliver
Users receive a secure dashboard rather than a static PDF.
Understanding Exia Bio — three levels of depth
Methodology
Platform Methodology
You are here
Asian-market deployment context
Population-context aware, not ethnicity-locked.
Sentinel is designed for deployment in Singapore and Malaysia, where customers may use reports from different laboratories, health-screening panels, and regional screening habits. The system is population-context aware but not ethnicity-locked.
Rather than assuming a single universal wellness template, Sentinel evaluates report completeness, marker coverage, pathway relevance, missing signals, and confidence limits. This allows the platform to support Asian-majority markets while remaining usable for local residents, expatriates, and people from diverse backgrounds living or testing in the region.
Non-diagnostic Boundary
Educational biomarker intelligence, not medical care.
Exia Bio does not diagnose disease, prescribe treatment, replace licensed medical consultation, or provide emergency medical review. Exia Bio highlights biomarker patterns, missing signals, and shifts away from expected stability for educational review. If a result appears outside the context Exia Bio is designed to explain, users should share their original laboratory report and Exia Bio dashboard with a licensed healthcare professional.